| abstract |
The present invention relates to uranium-chelating peptides, as well as their use for removing soil and water contamination contaminated with uranium and for detecting and treating people. Said peptide has four calmodulin calcium binding sites: residues selected at sites I: D20, D22 and D24 residues; sites II: residues selected at D56, D58 and N60 residues; sites III: D93, Residues selected at D95 and N97 residues; residues selected at sites IV: D129, D131 and D133 residues; the position indicates at least one, one, two of the human calmodulin sequences in the reference A helix-loop comprising a sequence of calmodulin loops comprising at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q of three or three residues -It has a helix type structure. |